1. Home
  2. ALZN vs JCSE Comparison

ALZN vs JCSE Comparison

Compare ALZN & JCSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALZN
  • JCSE
  • Stock Information
  • Founded
  • ALZN 2016
  • JCSE 1999
  • Country
  • ALZN United States
  • JCSE Singapore
  • Employees
  • ALZN N/A
  • JCSE N/A
  • Industry
  • ALZN Medicinal Chemicals and Botanical Products
  • JCSE Miscellaneous manufacturing industries
  • Sector
  • ALZN Health Care
  • JCSE Consumer Discretionary
  • Exchange
  • ALZN Nasdaq
  • JCSE Nasdaq
  • Market Cap
  • ALZN 7.0M
  • JCSE 8.1M
  • IPO Year
  • ALZN 2021
  • JCSE 2022
  • Fundamental
  • Price
  • ALZN $1.11
  • JCSE $1.48
  • Analyst Decision
  • ALZN Strong Buy
  • JCSE
  • Analyst Count
  • ALZN 1
  • JCSE 0
  • Target Price
  • ALZN $32.00
  • JCSE N/A
  • AVG Volume (30 Days)
  • ALZN 174.7K
  • JCSE 1.1M
  • Earning Date
  • ALZN 12-31-2024
  • JCSE 10-30-2024
  • Dividend Yield
  • ALZN N/A
  • JCSE 12.24%
  • EPS Growth
  • ALZN N/A
  • JCSE N/A
  • EPS
  • ALZN N/A
  • JCSE 0.12
  • Revenue
  • ALZN N/A
  • JCSE $14,723,999.00
  • Revenue This Year
  • ALZN N/A
  • JCSE N/A
  • Revenue Next Year
  • ALZN N/A
  • JCSE N/A
  • P/E Ratio
  • ALZN N/A
  • JCSE $11.99
  • Revenue Growth
  • ALZN N/A
  • JCSE N/A
  • 52 Week Low
  • ALZN $1.06
  • JCSE $0.60
  • 52 Week High
  • ALZN $15.06
  • JCSE $2.39
  • Technical
  • Relative Strength Index (RSI)
  • ALZN 34.55
  • JCSE 52.50
  • Support Level
  • ALZN $1.16
  • JCSE $1.42
  • Resistance Level
  • ALZN $1.33
  • JCSE $1.64
  • Average True Range (ATR)
  • ALZN 0.09
  • JCSE 0.18
  • MACD
  • ALZN 0.01
  • JCSE -0.01
  • Stochastic Oscillator
  • ALZN 17.86
  • JCSE 15.94

About ALZN Alzamend Neuro Inc.

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

About JCSE JE Cleantech Holdings Limited

JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The product lives of its cleaning systems and other equipment range from two to ten years. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. It derives a majority of its revenue from Singapore.

Share on Social Networks: